Search for: "ABBOTT v. ABBOTT"
Results 1701 - 1720
of 2,570
Sort by Relevance
|
Sort by Date
28 Feb 2011, 8:19 am
The court further quoted from Regents of the Univ. of Cal. v. [read post]
27 Feb 2011, 5:37 pm
Cases like Noelle v. [read post]
24 Feb 2011, 10:14 pm
By Jason Rantanen Centocor Ortho Biotech, Inc. v. [read post]
23 Feb 2011, 10:18 pm
Ariad Pharm., Inc. v. [read post]
23 Feb 2011, 9:59 pm
By Donald Zuhn -- Today, in Centocor Ortho Biotech, Inc. v. [read post]
23 Feb 2011, 9:49 am
Univ. of Rochester v. [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and pay-for-delay agreements (Patent… [read post]
21 Feb 2011, 8:13 am
The Court’s decision follows its decision in Abbott Labs. v. [read post]
20 Feb 2011, 9:57 pm
Abbott Laboratories et al. v. [read post]
20 Feb 2011, 8:16 pm
Currently there are proposals for the section to be abolished.It is apparent from the recent case of Abbott and Langdon (Costs) that if there is a finding that a party knowingly made a false statement or allegation in the proceedings, then section 117AB overrides the general discretion on costs under section 117 of the Family Law Act. [read post]
19 Feb 2011, 2:26 pm
United States v. [read post]
15 Feb 2011, 5:26 pm
: Novozymes v Danisco (Holman’s Biotech IP Blog) US: Preliminary injunction softened after claims are rejected in reexamination: Celsis In Vitor v CellzDirect (Reexamination Alert) Products Alpharen – EU: General Court: Boards of appeal are judges not doctors! [read post]
14 Feb 2011, 11:44 am
Citizens Planning Association v. [read post]
10 Feb 2011, 9:59 pm
According to the complaint, Wyeth claimed that Abbott's Xience V stent infringed U.S. [read post]
10 Feb 2011, 7:40 am
Patent No. 7,792,562 entitled DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS and owned by Abbott Diabetes Care. [read post]
10 Feb 2011, 7:40 am
Patent No. 7,792,562 entitled DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS and owned by Abbott Diabetes Care. [read post]
10 Feb 2011, 1:03 am
Abbott (Ky. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court… [read post]
8 Feb 2011, 2:36 pm
See Abbott Labs. v. [read post]
7 Feb 2011, 4:18 pm
Coal. v. [read post]
